Abstract:Objectives To observe the expression of basic fibroblast growth factor (bFGF) and its receptor Bek in giant cell tumor of bone (GCT) and explore the behavior and prognostic factors of GCT.Methods The expression of bFGF and its receptor Bek was tested by immunohistochemistry in 147 paraffin sections, which were made by using specimens of archival GCT (56 cases in recurrence group, 91 cases in non - recurrence group) . The gray level and positive area of bFGF and Bek expression were measured by image analysis. DNA content and S - phase fraction (SPF) in 147 cases with GCT were analyzed by flow cytom-etry. The parameters mentioned above and the correlated clinicopathologic factors including the age and gender of the patient, tumor size, soft tissue invasion and the surgical margin were analyzed by using multiple linear regression and stepwise regression to elucidate the relationship between these factors and the prognosis of GCT. Results bFGF and its receptor Bek were highly expressed in main component of oncocyte of GCT. The positive signals appeared in the cytoplasm of tumor cells. There were much more cells which showed strong positivity of bFGF and Bek including stromal cells with 1 to 3 nuclei and giant cells with 4 to 8 nuclei in recurrence group than that in non - recurrence group in which more negative multinucleated giant cells with dozens of nuclei were observed. The positive signals of bFGF and Bek were significantly higher in recurrence group than that in non - recurrence group. There were significant differences in the gray level and positive area of bFGF and Bek expression between recurrence group and non - recurrence group. The DNA content and SPF of recurrence group were significantly higher than that of non - recurrence group. Among these clinicopathologic factors, there were seven factors which had significant effect on the prognosis of GCT. They were listed from the strongest to the weakest as following: the surgical margin, the gray level of Bek expression, DNA content, the gray level of bFGF expression , SPF and the positive area of Bek and bFGF. Conclusions The expression intensity of bFGF and Bek prominently correlates with the biological behavior of GCT. The factors including surgical margin, expression intensity of bFGF and Bek, DNA content and SPF significantly influence the prognosis of GCT. Among them, the surgical margin had strongest effect on the outcome of GCT.

Expression of Vascular Endothelial Growth Factor and KDR in Giant Cell Tumor of Bone and Their Relationship with Tumor Proliferation and Angiogenesis

Expression of Human Vascular Endothelial Growth Factor in Ampullary Carcinoma and Its Significance

The Role of Vascular Endothelial Growth Factor Receptor (KDR) in Invasion and Metastasis of Gastric Cancer

Expressions of P53, Vascular Endothelial Growth Factor in Giant Cell Tumors of Bone and Their Significance

The expression of VEGF and Survivin in giant cell tumor of bone and the correlation with prognosis

Immunohistochemical Study of Association of Angiogenesis and Expression of TGFβ_1 and TGFβ_3 with Prognosis in Giant Cell Tumor of Bone

Expression and Significance of CD105 ,MMP-2 and MMP-9 in Giant Cell Tumor of Bone

Hypoxia-inducible factor expression in giant cell tumor of bone and its relationship with different pathological types

Expression of CD147, PCNA, VEGF, MMPs and Their Clinical Significance in the Giant Cell Tumor of Bones.

Expression of Matrix Metalloproteinase‐9 and CD34 in Giant Cell Tumor of Bone

Prognostic Significance of Vascular Endothelial Growth Factor Expression and Microvessel Density in Carcinoma of Ampulla of Vater.

Expression of Vascular Endothelial Growth Factor and Its Kinase Insert Domain Containing Receptor in Colorectal Cancer Tissue and Its Relation with the Prognosis of Colorectal Carcinoma

The Expression and Clinical Significance of Vascular Endothelial Growth Factor-C in Gastric Cancer Tissues

Expressions of PTEN and MMP-7、VEGF in Giant Cell Tumor of Bone (GCT)

Study on Expression of Basic Fibroblast Growth Factor and Its Receptor in Giant Cell Tumor of Bone and Its Prognostic Factors

Expression and clinical study of vascular endothelial growth factor and its receptors FLT-1, FLK-1/KDR in non-small cell lung cancer

Relations between the expression of VEGF and its receptor KDR and the progression of epithelial ovarian cancer

[Expression and Clinical Significance of Vascular Endothelial Growth Factor and Its Receptors in Multiple Myeloma].

Expression of VEGF Receptor KDR in Different Originated Carcinomas

Expressions of CD133 and Ki-67 in giant cell tumor of bone and their clinical significance

Expression of Vascular Endothelial Growth Factor (VEGF) in Breast